Jane E Minturn Selected Research

Jane E Minturn Research Topics

Disease

17	Neoplasms (Cancer) 10/2022 - 11/2005
9	Neuroblastoma 09/2012 - 11/2002
6	Glioma (Gliomas) 01/2022 - 03/2011
4	Diffuse Intrinsic Pontine Glioma 01/2022 - 11/2020
4	Brain Neoplasms (Brain Tumor) 06/2019 - 01/2011
1	Brain Stem Neoplasms (Brain Stem Tumor) 01/2022
1	Thrombocytopenia (Thrombopenia) 11/2021
1	Medulloblastoma 01/2021
1	Hypersensitivity (Allergy) 01/2016
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 06/2013
1	Residual Neoplasm 12/2011
1	Renal Cell Carcinoma (Grawitz Tumor) 09/2011
1	Combined Pituitary Hormone Deficiency 07/2011
1	Carcinogenesis 01/2011
1	Spontaneous Remission 05/2009

Drug/Important Bio-Agent (IBA)

5	dipinacoline glutamateIBA 01/2022 - 06/2013
5	Brain-Derived Neurotrophic Factor (BDNF)IBA 09/2011 - 11/2002
3	lestaurtinibIBA 12/2011 - 03/2010
3	Pharmaceutical PreparationsIBA 12/2011 - 11/2002
3	LigandsIBA 06/2011 - 11/2002
2	Irinotecan (Camptosar)FDA LinkGeneric 11/2021 - 09/2012
2	Histones (Histone)IBA 11/2020 - 01/2011
2	Biological ProductsIBA 06/2013 - 05/2009
2	Temozolomide (Temodar)FDA LinkGeneric 09/2012 - 02/2012
2	Phosphotransferases (Kinase)IBA 12/2011 - 10/2011
2	Nerve Growth Factor (NGF)IBA 05/2009 - 11/2002
1	Topoisomerase I InhibitorsIBA 11/2021
1	Tyrosine Kinase InhibitorsIBA 11/2021
1	Lipase (Acid Lipase)FDA Link 11/2021
1	Sorafenib (BAY 43-9006)FDA Link 11/2021
1	Carboplatin (JM8)FDA LinkGeneric 01/2016
1	Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA 09/2012
1	O(6)-benzylguanineIBA 02/2012
1	Isotretinoin (Accutane)FDA LinkGeneric 12/2011
1	tyrosine receptor (receptor, tyrosine)IBA 12/2011
1	FenretinideIBA 12/2011
1	RetinoidsIBA 12/2011
1	lissamine rhodamine B (sulforhodamine B)IBA 12/2011
1	aspartoacylaseIBA 09/2011
1	Amino Acids FDA Link 09/2011
1	aminoacylase I (aminoacylase)IBA 09/2011
1	tipifarnib (R115777)IBA 03/2011
1	Farnesyltranstransferase (Farnesyltransferase)IBA 03/2011
1	MicroRNAs (MicroRNA)IBA 01/2011
1	A-factor (Streptomyces)IBA 01/2011
1	Proteins (Proteins, Gene)FDA Link 01/2011
1	Topotecan (Hycamtin)FDA LinkGeneric 01/2011
1	ErbB Receptors (EGF Receptor)IBA 11/2005
1	Gefitinib (Iressa)FDA Link 11/2005
1	Epidermal Growth Factor (EGF)IBA 11/2005
1	Indicators and Reagents (Reagents)IBA 11/2002
1	DNA (Deoxyribonucleic Acid)IBA 11/2002
1	Etoposide (VP 16)FDA LinkGeneric 11/2002
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2002
1	Cisplatin (Platino)FDA LinkGeneric 11/2002

Therapy/Procedure

8	Therapeutics 10/2022 - 05/2009
4	Radiotherapy 01/2021 - 03/2011
3	Drug Therapy (Chemotherapy) 09/2012 - 11/2002
1	General Anesthesia 01/2022
1	Anesthesia 01/2022
1	Hematopoietic Stem Cell Transplantation 01/2022
1	Adjuvant Chemotherapy 01/2021
1	Craniospinal Irradiation 01/2021
1	Chemoradiotherapy 12/2011
1	Aftercare (After-Treatment) 07/2011